MedTrace Logo

Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear

NCT00691197 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 246

Last updated 2015-07-22

Study results available
· View outcomes & findings →

Summary

Testing the Safety and Acceptability of Using a Rewetting Drop with Contact Lenses

Conditions

  • Ametropia

Interventions

DEVICE

Carboxymethylcellulose sodium and Glycerin

Eye drops used at least 4 times per day, 1-2 drops in each eye while wearing contact lenses.

DEVICE

Carboxymethylcellulose sodium

Eye drops used at least 4 times per day, 1-2 drops in each eye while wearing contact lenses.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00691197 on ClinicalTrials.gov